EUVIMEDEUVIMED entdecken
Crossref

Human serum albumin microspheres synchronously loaded with ZIF-8 and triptolide (TP) for the treatment of intrahepatic cholangiocarcinoma

Fuxin Li, Ruiqiang Cai, Zipian Ye, Li Yang, Xianshuai Qiu, Xueqiang Sun

Journal of Biomaterials Applications · 2025

DOI: 10.1177/08853282251318872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Fuxin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: The people's hospital of Hezhou, Guangxi, China. Hauptthemen laut MEDLINE: Phenanthrenes, Cholangiocarcinoma, Diterpenes, Serum Albumin, Human. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and remains a fatal malignancy in most patients. Only 20% to 30% of patients can be treated with potentially curative surgical resection. Local therapies such as radioembolization and hepatic arterial perfusion may be a more effective treatment strategy. The active ingredients of natural plants have aroused wide interest in the treatment of tumors. Triptolide shows toxic effects on a variety of epithelioid carcinoma cells. However, there is currently a lack of suitable delivery system for the treatment of ICC. In this study, organometallic framework material ZIF-8 was chosen to load TP, and then encapsuled in HSA micro-nanoparticles for the perfusion treatment of ICC. The results of SEM, XRD, and FTIR showed that ZIF-8 nanoparticles were encapsuled in HSA micro-nanoparticles. ZIF-8 nanoparticles (57.89 ± 12.24%) and TP@ZIF-8/HSA (36.8 ± 4.71%) micro-nanoparticles could significantly inhibited proliferation of RBE cell. Also, TP@ZIF-8/HSA micro-nanoparticles of all groups exhibited favorable cytocompatibility to L929 cells and hemocompatibility. RT-qPCR and western blot showed that ZIF-8 and TP induced apoptosis in cancer cells through mitochondria-related pathways. The results demonstrated that TP@ZIF-8/HSA was a potential chemotherapy candidate for the treatment of ICC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenanthrenesCholangiocarcinomaDiterpenesSerum Albumin, HumanMetal-Organic FrameworksBile Duct NeoplasmsAntineoplastic Agents, AlkylatingHumansEpoxy CompoundsMicrospheresCell Line, TumorAnimalsCell ProliferationNanoparticlesApoptosisDrug Carriers

Stichwörter der Autor:innen

Human serum albuminTriptolideZIF-8intrahepatic cholangiocarcinoma

Substanzen

triptolideEpoxy CompoundsPhenanthrenesDiterpenesSerum Albumin, HumanMetal-Organic FrameworksDrug CarriersAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • The people's hospital of Hezhou, Guangxi, China.
  • The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Center of Orthopedics and Sports Medicine, Heyou Hospital, Foshan, Guanzhou, China.
  • The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.

Förderung

  • Natural Science Foundation of Gansu Province China

Zitieren

APA

Li, F., Cai, R., Ye, Z., Yang, L., Qiu, X., & Sun, X. (2025). Human serum albumin microspheres synchronously loaded with ZIF-8 and triptolide (TP) for the treatment of intrahepatic cholangiocarcinoma. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251318872

Vancouver

Li F, Cai R, Ye Z, Yang L, Qiu X, Sun X. Human serum albumin microspheres synchronously loaded with ZIF-8 and triptolide (TP) for the treatment of intrahepatic cholangiocarcinoma. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251318872

BibTeX
@article{Li2025,
  author = {Li, Fuxin and Cai, Ruiqiang and Ye, Zipian and Yang, Li and Qiu, Xianshuai and Sun, Xueqiang},
  title = {Human serum albumin microspheres synchronously loaded with ZIF-8 and triptolide (TP) for the treatment of intrahepatic cholangiocarcinoma},
  journal = {Journal of Biomaterials Applications},
  year = {2025},
  doi = {10.1177/08853282251318872}
}
Kostenlos starten →